Table 1 Clinicopathological features of 60 gastric cancer patients and the expression of circUBE2Q2.
Parameters | Group | circUBE2Q2 expression | |||
---|---|---|---|---|---|
Cases | Low | High | P-value | ||
Gender | Female | 20 | 8 | 12 | 0.2733 |
 | Male | 40 | 22 | 18 |  |
Age at surgery (years) | ≥50 | 48 | 23 | 25 | 0.5186 |
 | <50 | 12 | 7 | 5 |  |
T grade | T1 + T2 | 18 | 6 | 12 | 0.091 |
 | T3 + T4 | 42 | 24 | 18 |  |
Lymphatic invasion | Negative(N0) | 10 | 8 | 2 | 0.0377* |
 | Positive (N1–N3) | 50 | 22 | 28 |  |
Tumor site | Cardiac | 27 | 14 | 13 | 0.7952 |
 | Non-cardiac | 33 | 16 | 17 |  |
Stage | I–II | 21 | 12 | 9 | 0.4168 |
 | III–IV | 39 | 18 | 21 |  |
Size (cm) | <3 | 35 | 22 | 13 | 0.0184* |
 | ≥3 | 25 | 8 | 17 |  |
Histology grade | Intestinal type | 29 | 13 | 16 | 0.4383 |
 | Diffuse type | 31 | 17 | 14 |  |